# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-17-004340
Filing Date
2017-04-28
Accepted
2017-04-28 08:00:22
Documents
3
Period of Report
2017-06-14
Effectiveness Date
2017-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | def14a0417_immucellcorp.htm | DEF 14A | 307288
2 | GRAPHIC | proxy_001.jpg | GRAPHIC | 408913
3 | GRAPHIC | proxy_002.jpg | GRAPHIC | 325950
| Complete submission text file | 0001213900-17-004340.txt |  | 1320576

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12934 | Film No.: 17791709
SIC: 2835 In Vitro & In Vivo Diagnostic Substances